What type of patient would you avoid using sevofluorane for during a 4-6 hour surgery?

What type of patient would you avoid using sevofluorane for during a 4-6 hour surgery?

• A. Obese woman with creatinine 2.4
• B. Healthy male with normal creatinine
• C. Elderly person with heart disease
• D. Young adult with asthma

Answer: (A)

Sevoflurane is generally considered safe for use in a variety of patients due to its favorable properties, such as low blood-gas solubility and minimal airway irritation. However, in certain patient populations, its use may be approached with caution. In the context of an obese woman with a creatinine level of 2.4, the concern lies primarily with her renal function. A creatinine level of 2.4 suggests impaired kidney function or renal insufficiency. Inhalational anesthetics like sevoflurane can be safely used, but in patients with unresolved renal conditions, the absorption and excretion of anesthetic agents might be affected. Furthermore, obesity often complicates surgical and anesthetic management due to associated comorbidities such as obstructive sleep apnea and cardiovascular problems. Choosing to avoid sevoflurane in this scenario might be based on the potential risks associated with impaired renal function during a lengthy procedure, as prolonged exposure to inhalants may lead to accumulation and additional strain on an already compromised renal system. While sevoflurane itself is not contraindicated in patients with renal impairment, the combination of obesity and reduced renal function may increase the risk of adverse outcomes, thereby warranting caution. The other patient

Sevoflurane is generally considered safe for use in a variety of patients due to its favorable properties, such as low blood-gas solubility and minimal airway irritation. However, in certain patient populations, its use may be approached with caution.

In the context of an obese woman with a creatinine level of 2.4, the concern lies primarily with her renal function. A creatinine level of 2.4 suggests impaired kidney function or renal insufficiency. Inhalational anesthetics like sevoflurane can be safely used, but in patients with unresolved renal conditions, the absorption and excretion of anesthetic agents might be affected. Furthermore, obesity often complicates surgical and anesthetic management due to associated comorbidities such as obstructive sleep apnea and cardiovascular problems.

Choosing to avoid sevoflurane in this scenario might be based on the potential risks associated with impaired renal function during a lengthy procedure, as prolonged exposure to inhalants may lead to accumulation and additional strain on an already compromised renal system. While sevoflurane itself is not contraindicated in patients with renal impairment, the combination of obesity and reduced renal function may increase the risk of adverse outcomes, thereby warranting caution.

The other patient